Tiny vesicles tested to heal fragile skin in rare genetic disease
NCT ID NCT07230223
Summary
This study is testing a new topical treatment called Ev.FV for people with dystrophic epidermolysis bullosa (DEB), a rare genetic condition that causes extremely fragile skin and painful wounds. The treatment uses tiny, cell-free particles derived from stem cells, applied directly to wounds, with the goal of helping them heal faster and reducing pain. Researchers will measure how well and how safely these particles work in 20 participants over the course of the study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WOUND HEAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alzahra Hospital
RECRUITINGIsfahan, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.